Rate-话题@MedSci

#Rate#

9篇内容 | 580人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2036771, encodeId=49e22036e71ad, content=<a href='/topic/show?id=0bd715152b1' target=_blank style='color:#2F92EE;'>#Rate#</a>, objectTitle=Carbohydrate Polymers：灵芝减肥、治疗高脂血症有依据, objectType=article, longId=207951, objectId=58c720e9518c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c720e9518c, replyNumber=0, likeNumber=54, createdTime=2021-11-01, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c720e9518c, moduleTitle=Carbohydrate Polymers：灵芝减肥、治疗高脂血症有依据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58c720e9518c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2036770, encodeId=c6172036e701a, content=<a href='/topic/show?id=0bd715152b1' target=_blank style='color:#2F92EE;'>#Rate#</a>, objectTitle=如何通俗地理解Family-wise error rate(FWER)和False discovery rate(FDR), objectType=article, longId=188433, objectId=3b6e188433e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b6e188433e0, replyNumber=0, likeNumber=33, createdTime=2020-09-01, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b6e188433e0, moduleTitle=如何通俗地理解Family-wise error rate(FWER)和False discovery rate(FDR), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b6e188433e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2036769, encodeId=79a32036e6925, content=<a href='/topic/show?id=0bd715152b1' target=_blank style='color:#2F92EE;'>#Rate#</a>, objectTitle=JACC：在退行性主动脉瓣膜中使用ACURATE Neo进行瓣中瓣植入, objectType=article, longId=183547, objectId=faf318354eac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=faf318354eac, replyNumber=0, likeNumber=45, createdTime=2020-02-04, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=faf318354eac, moduleTitle=JACC：在退行性主动脉瓣膜中使用ACURATE Neo进行瓣中瓣植入, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=faf318354eac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2036768, encodeId=39172036e686d, content=<a href='/topic/show?id=0bd715152b1' target=_blank style='color:#2F92EE;'>#Rate#</a>, objectTitle=LimaCorporate在医院院区内领导建立3D打印站点, objectType=article, longId=157639, objectId=6d6d15e639ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d6d15e639ef, replyNumber=0, likeNumber=48, createdTime=2019-06-26, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d6d15e639ef, moduleTitle=LimaCorporate在医院院区内领导建立3D打印站点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d6d15e639ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2036766, encodeId=cc872036e6606, content=<a href='/topic/show?id=0bd715152b1' target=_blank style='color:#2F92EE;'>#Rate#</a>, objectTitle=Diabetes Care：新型选择性PPARα调节剂Pemafibrate对2型糖尿病和高甘油三酯血症患者脂质代谢和糖代谢的影响！, objectType=article, longId=125507, objectId=a34212550e33, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a34212550e33, replyNumber=0, likeNumber=40, createdTime=2018-01-07, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a34212550e33, moduleTitle=Diabetes Care：新型选择性PPARα调节剂Pemafibrate对2型糖尿病和高甘油三酯血症患者脂质代谢和糖代谢的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a34212550e33)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2036767, encodeId=8e2b2036e67e0, content=<a href='/topic/show?id=0bd715152b1' target=_blank style='color:#2F92EE;'>#Rate#</a>, objectTitle=JACC：1000名患者使用ACURATE neo经导管心脏瓣膜欧洲上市后登记的1年预后（SAVI-TF登记）, objectType=article, longId=144673, objectId=d46f1446e3b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d46f1446e3b4, replyNumber=0, likeNumber=35, createdTime=2019-03-07, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d46f1446e3b4, moduleTitle=JACC：1000名患者使用ACURATE neo经导管心脏瓣膜欧洲上市后登记的1年预后（SAVI-TF登记）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d46f1446e3b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2036765, encodeId=3c632036e650a, content=<a href='/topic/show?id=0bd715152b1' target=_blank style='color:#2F92EE;'>#Rate#</a>, objectTitle=Lima Corporate宣布任命新的临时首席财务官, objectType=article, longId=120772, objectId=518c120e72c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=518c120e72c8, replyNumber=0, likeNumber=38, createdTime=2018-06-22, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=518c120e72c8, moduleTitle=Lima Corporate宣布任命新的临时首席财务官, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=518c120e72c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2036764, encodeId=b8612036e6441, content=<a href='/topic/show?id=0bd715152b1' target=_blank style='color:#2F92EE;'>#Rate#</a>, objectTitle=Lima Corporate, Paolo Riccardi, 首席财务官, objectType=article, longId=115651, objectId=9b26115651c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b26115651c8, replyNumber=0, likeNumber=34, createdTime=2018-04-07, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b26115651c8, moduleTitle=Lima Corporate, Paolo Riccardi, 首席财务官, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b26115651c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2036763, encodeId=043d2036e6312, content=<a href='/topic/show?id=0bd715152b1' target=_blank style='color:#2F92EE;'>#Rate#</a>, objectTitle=ASCO：abiraterone与前列腺癌标准疗法联用，存活率可提高40%, objectType=article, longId=100681, objectId=56d41006816f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56d41006816f, replyNumber=0, likeNumber=34, createdTime=2018-04-16, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56d41006816f, moduleTitle=ASCO：abiraterone与前列腺癌标准疗法联用，存活率可提高40%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56d41006816f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Rate

2020-05-29

jjjiang0199 (审核中...)

前往app查看评论内容

#Rate#

Carbohydrate Polymers：灵芝减肥、治疗高脂血症有依据

2021-11-01

jjjiang0199 (审核中...)

前往app查看评论内容

#Rate#

如何通俗地理解Family-wise error rate(FWER)和False discovery rate(FDR)

2020-09-01

jjjiang0199 (审核中...)

前往app查看评论内容

#Rate#

JACC：在退行性主动脉瓣膜中使用ACURATE Neo进行瓣中瓣植入

2020-02-04

jjjiang0199 (审核中...)

前往app查看评论内容

#Rate#

LimaCorporate在医院院区内领导建立3D打印站点

2019-06-26

jjjiang0199 (审核中...)

前往app查看评论内容

#Rate#

Diabetes Care：新型选择性PPARα调节剂Pemafibrate对2型糖尿病和高甘油三酯血症患者脂质代谢和糖代谢的影响！

2018-01-07

jjjiang0199 (审核中...)

前往app查看评论内容

#Rate#

JACC：1000名患者使用ACURATE neo经导管心脏瓣膜欧洲上市后登记的1年预后（SAVI-TF登记）

2019-03-07

柳叶一刀 (审核中...)

前往app查看评论内容

#Rate#

Lima Corporate宣布任命新的临时首席财务官

2018-06-22

jjjiang0199 (审核中...)

前往app查看评论内容

#Rate#

Lima Corporate, Paolo Riccardi, 首席财务官

2018-04-07

jjjiang0199 (审核中...)

前往app查看评论内容

#Rate#

ASCO：abiraterone与前列腺癌标准疗法联用，存活率可提高40%

2018-04-16

科室
- - 订阅+
  - 更多科室
工具
服务